Promising perspectives for the application of SDS Optic's inPROBE technology platform for protein expression determination
LUBLIN, Poland, April 25, 2024 -- An inherent feature of oncology is personalization, i.e., conversion from the fit-to-all strategy based on applying the same chemotherapy regimens to all patients...
Source: marketscreener.com